Compounds > methylprednisolone

methylprednisolone and Porokeratosis

methylprednisolone has been researched along with Porokeratosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
di Meo, N; Fluehler, C; Perkan, V; Trevisan, G1
Spiliopoulos, T; Tsambaos, D1

Other Studies

2 other study(ies) available for methylprednisolone and Porokeratosis

ArticleYear
Disseminated superficial porokeratosis and pyoderma gangrenosum.
    Dermatology online journal, 2010, Oct-15, Volume: 16, Issue:10

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clofazimine; Humans; Leg Dermatoses; Leg Injuries; Male; Methylprednisolone; Porokeratosis; Pyoderma Gangrenosum; Skin Ulcer

2010
Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression.
    Journal of the American Academy of Dermatology, 1993, Volume: 28, Issue:4

    Topics: Adenocarcinoma; Dermatomyositis; Female; Humans; Methylprednisolone; Middle Aged; Ovarian Neoplasms; Paraneoplastic Syndromes; Porokeratosis

1993